Home › Premier Biotech Wins FDA Clearance for Drugs of Abuse Assays

Premier Biotech Wins FDA Clearance for Drugs of Abuse Assays

Sep 25, 2018

NEW YORK (360Dx) — Premier Biotech said today it has received 510(k) clearance from the US Food and Drug Administration for two additional assays for use on its OralTox oral fluid-based drugs of abuse device.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
19
Featured Webinar

One Test May Not Fit All: Evaluation of Point-of-Care Assays for Influenza Testing

In this webinar, Dr. Matthew Faron, a pathologist from the Medical College of Wisconsin, will share results of a comparison study of three rapid influenza assays.

 

Mar
27
Featured Webinar

How One NGS Core Lab Reduced Sequencing Costs with a Novel Library Normalization Kit

Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

What's Popular?

In Point-of-Care Testing

  1. SAW Diagnostics Wins Platform Development Funds for POC MDx Sample Prep System

  2. Genomtec Plans 2021 Launch for Handheld MDx Platform, Respiratory Disease Panel

    Premium

  3. Blood Test to Measure Pain Aims to Reduce Opioid Use

    Premium

  4. Sight Diagnostics Closes $27.8M Series C Funding

  5. Tuberculosis Drug Resistance Study Finds Increased Mortality From Testing Flaws

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.